Bcr Abl News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bcr Abl. Real-time updates on events, politics, business and more.

First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib vs Imatinib in Newly Diagnosed Ph+ ALL

May 22, 2023

Expert Elias Jabbour, MD, reviews clinical data from the PhALLCON study of ponatinib vs imatinib in patients with Ph+ acute lymphocytic leukemia and considers its clinical implications.

Elias Jabbour First Report Comparing Ponatinib Newly Diagnosed Acute Lymphocytic Leukemia Call Cancer

Source: onclive.com

MyJournals.org - Science - '[ASAP] De Novo Linear Phosphorylation Site Motifs for BCR-ABL Kinase Revealed by Phospho-Proteomics in Yeast' (Journal of Proteome Research)

April 14, 2023

MyJournals.org - Science - [ASAP] De Novo Linear Phosphorylation Site Motifs for BCR-ABL Kinase Revealed by Phospho-Proteomics in Yeast (Journal of Proteome Research)

Proteomics In Yeast Journal Of Proteome Research Journal Of Proteome Research Proteome Research Novo Linear Phosphorylation Site Motifs Size Separation Intact Mass Apolipoprotein Proteoform Analysis

Source: myjournals.org

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Bcr Abl News Today

First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib vs Imatinib in Newly Diagnosed Ph+ ALL

MyJournals.org - Science - '[ASAP] De Novo Linear Phosphorylation Site Motifs for BCR-ABL Kinase Revealed by Phospho-Proteomics in Yeast' (Journal of Proteome Research)

Explore More Categories